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Abstract
Background: Epidemiological evidence demonstrates that exposure to traffic-derived pollution worsens respiratory
symptoms in asthmatics, but controlled human exposure studies have failed to provide a mechanism for this effect.
Here we investigated whether diesel exhaust (DE) would induce apoptosis or proliferation in the bronchial
epithelium in vivo and thus contribute to respiratory symptoms.
Methods: Moderate (n = 16) and mild (n = 16) asthmatics, atopic non-asthmatic controls (rhinitics) (n = 13) and healthy
controls (n = 21) were exposed to filtered air or DE (100 μg/m3) for 2 h, on two separate occasions. Bronchial biopsies
were taken 18 h post-exposure and immunohistochemically analysed for pro-apoptotic and anti-apoptotic proteins
(Bad, Bak, p85 PARP, Fas, Bcl-2) and a marker of proliferation (Ki67). Positive staining was assessed within the epithelium
using computerized image analysis.
Results: No evidence of epithelial apoptosis or proliferation was observed in healthy, allergic or asthmatic airways
following DE challenge.
Conclusion: In the present study, we investigated whether DE exposure would affect markers of proliferation and
apoptosis in the bronchial epithelium of asthmatics, rhinitics and healthy controls, providing a mechanistic basis for the
reported increased airway sensitivity in asthmatics to air pollutants. In this first in vivo exposure investigation, we found
no evidence of diesel exhaust-induced effects on these processes in the subject groups investigated.
Background
Outdoor air pollution is of growing concern worldwide,
and is linked to an increase in both cardiovascular and
respiratory disease [1]. Children, the elderly and subjects
with pre-existing respiratory or cardiovascular diseases
have been demonstrated to be susceptible groups [2–4].
There is evidence that exacerbations of pre-existing
asthma are attributed to exposure to pollutants related
to road traffic [5]. Diesel exhaust exposures have also
been shown to induce oxidative injury to the airways, lead-
ing to inflammation and increased risk of sensitisation [6].
In an attempt to understand the mechanisms respon-
sible for these adverse health effects in humans, controlled
exposure studies employing diesel exhaust (DE) have been
performed both in healthy individuals and in subjects with
established allergic diseases (asthma and rhinitis). These
studies have shown that healthy individuals respond
acutely to DE challenge with a marked neutrophilic airway
inflammation [7–11]. In asthmatics, increased bronchial
hyperresponsiveness to methacholine is evident follow-
ing exposure to high ambient DE concentrations [12].
However, this occurs with no evidence of augmented
airway inflammation in terms of diesel exhaust-induced
changes in submucosal inflammatory cell number or
* Correspondence: S.J.Wilson@southampton.ac.uk
2Histochemistry Research Unit, Clinical and Experimental Sciences, Faculty of
Medicine, University of Southampton, Southampton, UK
4Histochemistry Research Unit, Sir Henry Wellcome Laboratories, Mailpoint
894, Level B, South Block, Southampton General Hospital, Tremona Road,
Southampton, UK
Full list of author information is available at the end of the article
© 2015 Behndig et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this
article, unless otherwise stated.
Behndig et al. BMC Pulmonary Medicine  (2015) 15:99 
DOI 10.1186/s12890-015-0096-x
adhesion molecule expression [7]. The only responses
reported in the asthmatic airway following DE have
been increased epithelial expression of IL-10 [13] and
enhanced sputum IL-6 levels [12]. In another study,
asthmatics were exposed to DE in combination with cat
allergen, again without any signs of an enhanced airway
inflammation [14].
The bronchial epithelium forms a barrier between the
external environment and the underlying lung mucosa.
Epithelial integrity is usually maintained due to a balance
between apoptotic and proliferative processes [15], with
the relative activation of the positive and negative regu-
latory pathways of apoptosis ultimately determining cell
fate [15]. The Bcl-2 family are key regulators of the
mitochondrial apoptosis pathway and include the pro-
apoptosis members Bad and Bak and the anti-apoptosis
member Bcl-2 [15–17]. Another pathway of importance
is the TNFα receptor pathway, which includes the recep-
tor Fas. Binding to these receptors leads to activation of
initiator caspases. These two pathways are also termed
the intrinsic and extrinsic pathways and they converge at
the effector caspases, including caspase 3, and lead to
cleavage of poly (ADP-ribose) polymerase (PARP) into a
C terminal 85 kDa peptide fragment [18].
There have been some studies in human subjects, or
samples derived from humans, investigating apoptosis in
asthma and following exposure to DE. Evidence supports
increased apoptosis in asthma, in that the damaged bron-
chial epithelium found in asthmatics has been related to
the degree of bronchial hyperresponsiveness [19, 20]. In a
study by Bucchieri employing bronchial biopsies from
asthmatics, increased epithelial apoptosis was demon-
strated in terms of a greater expression of the caspase
cleavage product p85 PARP, compared to healthy controls
[21]. Furthermore, using primary epithelial cell cultures,
the asthmatic epithelium was shown to be more suscep-
tible to oxidant-induced apoptosis compared with normal
controls [21]. In vitro studies using epithelial cell lines
(A549) have demonstrated that exposure to particulate
matter (PM) leads to increased apoptosis [22–24]. Apop-
tosis is further enhanced in cystic fibrosis epithelial cell
lines compared to controls [25]. The effects of PM on the
apoptosis pathway in vivo and on subjects with pre-
existing lung disease are unknown. The lack of an in-
creased airway inflammation following exposure to DE
has led us to hypothesize that other mechanisms, apart
from airway inflammatory responses, such as apoptosis,
may account for the clinical outcomes observed in asth-
matics following exposure to traffic-derived pollution.
In the present study, we hypothesised that increased
apoptosis, or impaired proliferative responses could poten-
tially enhance the penetration of bronchoconstrictive
stimuli to the airway wall, potentially explaining the
increased sensitivity of asthmatics to symptoms during
periods of high pollution. The specific aim in this study
was to explore whether DE-exposure would affect pro-
apoptotic and anti-apoptotic proteins and markers of
proliferative responses in the bronchial airways. This
study included both mild and moderate asthmatics
along with healthy controls, as previously described [7].
In addition, due to the observed differential responses
to DE in asthmatics and healthy control subjects, atopic
non-asthmatics (subjects with allergic rhinitis) were
also included. We and others have shown evidence of
lower airway inflammation of atopic non-asthmatics that
is intermediary between that observed in the bronchial
mucosa of asthmatics versus healthy subjects [26–28].
Furthermore, in a controlled DE exposure study of allergic
rhinitics, we found that the DE-induced airway inflamma-
tory response was similar to that observed in asthmatic
airways [29].
Methods
This current study was performed as a follow-up investi-
gation of a larger study addressing DE-induced responses
in the airways of healthy, rhinitic and asthmatic subjects
[7, 29], using archived biopsies. Subjects included healthy
controls (non-asthmatic, non-atopic) (n = 21), allergic rhi-
nitics without asthma (atopic controls) (n = 13), asthmatics
on short acting β-2 agonists on demand (n = 16) and asth-
matics on inhaled corticosteroids (200–1200 μg daily)
(n = 16). Baseline demographics of each group are summa-
rized in Table 1. All participants gave their informed con-
sent and the local ethics committee of Umeå University
approved the study, which was performed in accordance
with the declaration of Helsinki.
Subjects were exposed to filtered air or diesel exhaust
(100 μg/m3) for 2 h, on two separate occasions, at least
3 weeks apart, in a randomised order, as previously de-
scribed [7, 29]. During the exposures, subjects alternated
exercise on a bicycle ergometer (minute ventilation =
20 L/min/m2 body surface area) with rest at 15-min inter-
vals. This exposure setup was used to model a moderate
level of outdoor activity in a high-polluted environment.
The diesel exhaust was generated from an idling 1991
Volvo diesel engine (Volvo TD45, 4.5 l, four cylinders,
680 rpm). The air within the exposure chamber was moni-
tored continuously and the steady state concentration of
PM10, gases and semi-volatiles during the diesel exposures
were 100 ± 12 μg/m3 for PM10, 9.1 ± 2.6 parts per million
(ppm) for carbon monoxide, 1.2 ± 0.1 ppm for nitrogen
monoxide, 0.39 ± 0.05 ppm for nitrogen dioxide, 1.7 ±
0.4 ppm for oxides of nitrogen and 1.1 ± 0.8 ppm for total
gaseous hydrocarbons (C3H8-equivalents), expressed as
mean ± SD. The PM mass was dominated by fine and ul-
trafine particles (<1 μm), and the mass median particle
diameter was 0.18 μm. Further details of the methods used
are described in detail in previous papers [7, 29].
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Bronchoscopy with collection of bronchial biopsies was
performed at the Department of Medicine, Division of
Respiratory Medicine and Allergy, University Hospital,
Umeå, Sweden, 18 h after exposure. The biopsies were
processed into glycol methacrylate (GMA) resin for im-
munohistochemistry using standardised protocols [30].
Immunohistochemical staining was performed using the
streptavidin biotin-peroxidase technique and monoclonal
antibodies directed against the pro-apoptotic markers, Bad
(Serotec, Kidlington, UK) and Bak (Serotec); the anti-
apoptotic marker Bcl-2 (Dako, Ely, UK); the death recep-
tor Fas (CD95) (TCS Biosciences ltd, Botolph Claydon,
UK); the caspase cleavage product p85 PARP (Promega,
Southampton, UK); and the cell proliferation marker Ki67
(Dako). Staining was visualised with diaminobenzidine
(DAB) and sections counterstained with haematoxylin.
Positive staining was analysed in lengths of intact well
orientated epithelium with the assistance of computerised
image analysis (KS400 software with a Zeiss Axioskop 2
microscope and Axiocam, Zeiss, Bicester, UK). For Ki67
the percentage positive nuclear area was determined and
for all other markers the percentage positive of the total
epithelium was assessed, based on the red/green/blue
(RGB) colour composition of the DAB staining [31]. In
brief, following standardisation of the computerised image
analysis system for light level and white balance digitised
images of the epithelium were captured. Threshold RGB
settings for the DAB staining were applied and adjusted to
select all the positive staining within the section. For epi-
thelial markers, the area of the epithelium was then delin-
eated interactively and the percentage of positive staining
within the epithelium calculated. For Ki67, DAB positive
thresholding was measured against RGB thresholding for
blue nuclear counterstaining.
Data were not normally distributed and are therefore
presented as medians with interquartile ranges (IQR). All
paired air versus diesel exhaust comparisons were per-
formed using the Wilcoxon signed rank test. The Kruskall
Wallis ANOVA test was initially used to test for differ-
ences in the response (change) to diesel exhaust versus air
between the four subject groups and differences at base-
line. If a significant difference was observed between the
four groups, the Mann Whitney U test was used for fur-
ther analyses. All statistical analyses were performed using
SPSS, version 21.0 (SPSS, Cary, North Carolina, USA). A
p-value of <0.05 was considered statistically significant.
Results
Following DE exposure a marked neutrophilic airway
inflammation was detected in healthy subjects, a response
that was absent in atopic individuals, as previously re-
ported [7, 29].
Representative images of the immunohistochemical
staining are shown in Fig. 1. There were no differences
in baseline (post air exposure) in the levels of any of the
markers of apoptosis or proliferation examined between
the four subject groups (Table 2). In the asthmatic and
rhinitic subjects, there was also no significant change
in expression (response) following exposure to DE
compared to air in any of these markers. However, in
the healthy control subjects the expression of Bcl-2 was
significantly lowered (p = 0.02) after DE compared to
filtered air: 4.5 % (IQR 0–11.44) after air versus 0.06 %
(IQR 0.01–0.62) following DE exposure. However, com-
parison of the response (change) to diesel versus air ex-
posure across the groups was not significant for Bcl-2
or any of the other markers investigated (Fig. 2).
Discussion
In this study, we investigated the hypothesis that DE
would lead to an increase in apoptosis accompanied by
impaired repair reflected by decreased proliferation in
the bronchial epithelium of asthmatics, providing a
mechanistic basis for their reported increased sensitivity
to air pollutants. Contrary to our hypothesis, in this
first in vivo exposure investigation, we found no
Table 1 Baseline demographics of the subjects in each study group
Healthy controls Allergic rhinitis Allergic asthma β2-agonists on demand Allergic asthma ICS-treatment
Number in group 21 13 16 16
Mean age years (range) 24 (21–29) 25 (22–34) 24 (18–32) 24 (19–41)
Gender (male:female) 12:9 6:7 8:8 8:8
FEV1 (% predicted) 98 ± 15 97 ± 15 99 ± 15 93 ± 8
PC20 (mg/mL)
a Not assessed >8.0 2.7 ± 1.8 >8.0
Skin prick test to pollens Negative Positive Positive Positive
SM eosinophils (cells/mlx104)a 0.0 (0.0-0.0) 0.4 (0.0-1.2) 0.1 (0.0-1.2) 0.0 (0.0-0.3)
SM mast cells (cells/mlx104) 19 (11–27) 16 (14–28) 27 (18–31) 16 (12–22)
SM neutrophils (cells/mlx104)a 61 (30–78) 57 (26–102) 47 (19–97) 98 (75–124)
SM = Submucosa. aSM-eosinophils and SM neutrophils were significantly different between the four groups, Kruskal-Wallis Test 0.017 and 0.033 respectively. Data
previously published [7, 29]
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evidence of the induction of these processes in either
mild-moderate asthmatics or allergic rhinitics following
DE challenge. Whilst we observed a decrease in Bcl-2
in the healthy subjects following diesel exposure com-
pared to air exposure, no significant changes were
found when comparing the Bcl-2 responses across the
groups.
Previous DE exposure studies have used different ex-
posure setups. We have reported a marked neutrophilic
inflammatory response in the airways of healthy
Fig. 1 Immunohistochemical staining. Photographs showing the epithelial expression of the pro-apoptotic markers Bad (a) and Bak (b), anti-apoptotic
marker Bcl-2 (c), the death receptor Fas (d), the caspase cleavage product p85 PARP (e) and the proliferation marker Ki67 (f). Positive staining is brown,
Scale bar is 20 μm
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Table 2 Data from immunohistochemistry staining of bronchial biopsies for markers of proliferation and apoptosis
Study group Healthy controls Allergic rhinitics Asthmatics β2 Asthmatics ICS
Exposure AIR DE AIR DE AIR DE AIR DE
Pro-apoptotic markers Bad 10.8 (5.5 - 20.1) 11.8 (9.1 - 23.3) 29.8 (9.6 - 34.2) 14.7 (4.0 - 27.4) 12.4 (6.0 - 20.7) 21.5 (4.3 - 41.4) 14.4 (6.2 - 22.8) 19.0 (10.7 - 28.8)
Bak 15.4 (3.8 - 36.4) 17.2 (9.1 - 28.0) 18.9 (8.8 - 31.7) 26.4 (8.3 - 31.9) 14.5 (10.3 - 33.7) 27.0 (13.1 - 38.5) 21.7 (13.3 - 33.2) 23.8 (8.6 - 28.7)
Anti-apoptotic marker Bcl-2 4.5 (0–11.4) 0.06* (0.01 - 0.6) 0.36 (0.19 - 1.2) 0.07 (0–44.2) 0.34 (0.02 - 5.1) 2.8 (0–17.1) 0.49 (0–3.3) 0.08 (0–5.1)
Death receptor Fas 2.8 (1.4 - 4.6) 1.4 (0.4 - 5.5) 1.8 (1.0 - 5.9) 1.7 (0.3 - 10.8) 1.9 (0.7 - 3.3) 1.8 (0.4 - 3.0) 1.3 (0.5 - 2.7) 2.0 (0.5 - 1.2)
Caspase cleavage product P85 PARP 1.7 (0.6 - 6.8) 1.7 (1.0 - 2.8) 3.8 (0.6 - 9.2) 2.6 (0.8 - 6.0) 2.2 (0.4 - 6.9) 4.3 (1.1 - 7.2) 2.1 (0.3- 4.6) 2.6 (0.1 - 4.1)
Proliferation marker Ki67 1.9 (0.1 - 5.0) 0.7 (0.3 - 3.6) 1.7 (0.4 - 14.6) 11.2 (1.5 - 34.1) 3.1 (0.6 - 10.2) 1.3 (0.2 - 3.4) 1.2 (0.2 - 11.9) 1.7 (0.9 - 8.0)
Data is given as the % positive staining within the epithelium calculated (median percentages and inter quartile ranges)














volunteers following exposure to 300 μg/m3 DE for one
hour, 6 h post-exposure [11]. In a previous study in
which healthy and asthmatics were exposed to DE at
PM10 108 μg/m
3 for 2 h, an increase in airway resistance
of similar magnitude was observed in both healthy and
asthmatics. Healthy subjects also developed airway in-
flammation 6 h after DE exposure, a response that was
absent in asthmatic subjects. However, epithelial staining
for the cytokine IL-10 was increased after DE in the asth-
matic group, a cytokine with potential anti-inflammatory
effects [13]. In the present study, we hypothesised that the
inflammatory response would be delayed in the allergic/
asthmatics subjects. We therefore exposed them to this
lower concentration (100 μg/m3) for 2 h and performed
the bronchoscopies 18 h post exposure. The dose was
chosen to mimic real world exposure more closely. This is
also a dose observed at kerbside locations for example in
London (http://www.londonair.org.uk/). Again we found a
neutrophilic airway inflammation in the healthy subjects
but not in subjects with allergic rhinitis or asthma. We
Fig. 2 Changes in expression of pro- and anti-apoptotic markers following exposure to diesel exhaust and air. Graphs showing the percentage
change in epithelial expression of the pro-apoptotic markers Bad and Bak; the anti-apoptotic marker Bcl-2; the death receptor Fas; the caspase
cleavage product p85 PARP; and the proliferation marker Ki67 in the bronchial epithelium of healthy controls (●), allergic rhinitics ( ) and
asthmatics on β2 agonists ( ) and on inhaled corticosteroids ( ) 18 h after a 2 h exposure to diesel exhaust (100 μg/m3) compared to filtered
air. Median values (−) for each group and significant p values are shown
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therefore hypothesised that other mechanisms such as
apoptosis would be affected by the DE exposure.
The failure of this study to confirm the previous in vitro
studies demonstrating increased apoptosis in A549 cells in
response to PM could suggest that these responses do not
extrapolate to the in vivo setting or may reflect differences
in methodologies between in vitro and in vivo systems
[22–25]. The A549 cell line is a transformed adenocarcin-
oma alveolar type II cell line. These cells are not normal
and have a squamous phenotype; therefore they are likely
to respond differently to PM than the in vivo stratified col-
umnar bronchial epithelium. Also, these investigators
used different methodologies to assess apoptosis, meas-
uring different end-points and features of apoptosis,
which again may account for the diverse outcomes
observed. Their techniques included: TUNEL (terminal
deoxynucleotidyl transferase-mediated dUTP nick-end
labelling) to assess DNA fragmentation [22, 23]; meas-
urement of DNA nucleosomal fragmentation by ELISA;
[23, 25] colourimetric assays for caspase 3 and 9 activa-
tion; [25] and Western blot to measure active caspase 3
and fragmentation of cytokeratins. In the immortalised
BEAS-2B bronchial epithelial cell line, which resembles
the in vivo bronchial epithelium more closely, no effect on
apoptosis following exposure to DE was observed [32],
which concurs with our findings. In their study, Cao et al.
measured antibody immunoreactivity to detect Bcl2 and
p85 protein by Western blotting, which is similar to the
immunohistochemical approach we employed.
There was variability in the expression of the markers
explored both at baseline (Table 1) and following DE ex-
posure (Table 2 and Fig. 2). It is well known that asthma
has a heterogeneous immunopathology that could to some
extent impact on this variability. However, this did not
result in any outliers in clinical responses following DE
exposure. The participants in the present study were all
stable in their disease. If the study had included subjects
with uncontrolled asthma, the results may have been
different.
Whilst none of the examined markers were altered in
the asthmatics or allergic rhinitics after exposure to DE,
this study is the first to report an in vivo effect of DE
exposure on Bcl-2 expression in healthy subjects. How-
ever, as this change in expression was not significant in
comparison with the other subject groups, this finding
should be considered with caution. Bcl-2 is known to be
a key apoptosis regulatory protein of the mitochondrial
death pathway, and has an anti-apoptotic function that
is closely associated with its level of expression [33].
Oxidative stress has been shown to downregulate Bcl-2
expression and thus promote apoptosis [34]. Exposure of
A549 cells to parabenzoquinone, a component of DE,
leads to decreased expression of Bcl-2 [35]. Also, over-
expression of Bcl-2 has been shown to delay apoptosis
of macrophages induced by chemical extracts from DE
[36] and to promote survival of cultured retinal pigment
epithelial cells exposed to oxidative damage [37].
The observed decrease in the anti-apoptotic marker
Bcl-2 would suggest an increase in apoptosis following
acute exposure to oxidative air pollution, which may be
a protective mechanism to remove damaged epithelium.
It has also been suggested that decreased apoptosis, if
accompanied by increased proliferation, may be a repair
response to protect the epithelium [38]. However, in the
present study, the decrease in Bcl-2 was not paralleled
by an increase in p85 PARP, and so we could therefore
not confirm that exposure to DE leads to increased
apoptosis, or an increase in Ki67 expression that would
suggest a proliferative response.
Whilst the lack of a measurable response to DE within
the bronchial epithelium in the asthmatic subjects may
reflect a difference between in vitro and in vivo exposure
(as discussed earlier), it is possible this may be due to
epithelial shedding of damaged cells. An impaired epi-
thelial barrier due to epithelial shedding [19, 20, 39] is a
characteristic feature of asthma, as is increased sensitiv-
ity to oxidative damage [21]. In the present study the
number of epithelial cells in bronchial lavages was very
low, and there were no signs of epithelial shedding in
any of the groups. Neither was there any sign of shred-
ding in the biopsy material. Another possible scenario
could have been that the exposure of an already fragile
sensitive epithelium to DE could already have led to
apoptosis and shedding into the bronchial lumen by
18 h. It may therefore be more appropriate to look at an
earlier time point after DE exposure. In this study we
did not observe a response assessed by changes in
markers of apoptosis or proliferation in the bronchial
epithelium of the allergic rhinitic subjects when exposed
to DE, suggesting their responses are similar to those
seen in asthmatics.
Whilst previous studies have reported increased markers
of apoptosis and proliferation in asthmatics [40–42], we
did not observe any differences in the expression of the
pro-apoptotic markers, Bad and Bak; the anti-apoptotic
marker Bcl-2; the death receptor Fas; the caspase cleavage
product p85 PARP; or the cell proliferation marker Ki67
between the subject groups when exposed to air. Druilhe
reports increased expression of Fas in the bronchial epi-
thelium of asthmatics compared to controls, but no differ-
ence in Fas L, Bcl-2 or PCNA [40]. p85 PARP was found
by Western blot in asthmatic epithelial cells, accompanied
by an increase in immunohistochemical staining for Ki67.
Such responses were not seen in healthy controls [41]. In
another study, Bcl-2 expression was increased in the
bronchial epithelium of asthmatic subjects compared to
controls, implying an anti-apoptotic effect, but in the
absence of PCNA positivity [42]. Following an asthma
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exacerbation, an increase in Bcl-2 expression in BAL
lymphocytes has been shown, but contrary to our
study, these asthmatics had a FEV1 that ranged between
62 and 83 % predicted, compared with 98 % in our
current study. The increase in Bcl-2 could therefore be
related to asthma severity [43]. There are also other
previous studies employing less severe asthmatics that
also failed to demonstrate differences in Bcl-2, Fas or
Ki67 compared to healthy controls [44].
Conclusion
These initial data do not support our original contention
that the heightened sensitivity of asthmatics to traffic de-
rived particulate matter might reflect an underlying imbal-
ance between cell clearance and proliferation in response
to DE; effectively enhancing the penetration of broncho-
constrictive stimuli to the airway wall. We acknowledge
that this interpretation is limited by the single time point
examined, and further studies will be required before we
can fully exclude the involvement of these pathways in the
induction of airway hyper-responsiveness after exposure
to particulate matter air pollution.
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